Immunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers?
نویسندگان
چکیده
منابع مشابه
Natural Language Processing: many questions, no answers
Computational Linguistics, as a subfield of Linguistics, or Natural Language Processing (NLP), as a subfield of Artificial Intelligence (two research areas that nowadays can be safely considered as merged) concentrate on the “study of computer systems for understanding and generating natural language” [10], in order to develop “a computational theory of language, using the notions of algorithms...
متن کاملPersonalized psychiatry: many questions, fewer answers.
Clinical practice in many areas of medicine is shifting toward personalized treatment. In other words, clinicians aim to treat patients based on their individual characteristics, including clinical presentation and/or biological markers. Biomarkers can help clinicians select the most effective treatments or reduce the risk of side effects by avoiding certain treatments in susceptible patients. ...
متن کاملUse of biomarkers in sepsis: many questions, few answers
Why do we use biomarkers in sepsis? There are several answers to this question. Some researchers argue that biomarkers are used to assess the prognosis of septic patients, (1) but why should we use a biomarker merely to determine whether a patient has a higher risk of death when currently available interventions are not able to modify the prognosis? (2) As we all know, dozens of randomized cont...
متن کاملMany Questions and Few Answers: On Conversión in English
Conversión is a well-known word-formation process which, a priori, seems relatively easy to identify. However, a cióse look at its basics brings to light some critical questions which still remain unanswered to this day. The very nature of this operation, and the concepts of full and partial conversión are therefore here examined in the light of a need for explicit criteria for recognition of a...
متن کاملPulmonary Cryptococcosis in the Immunocompetent Patient—Many Questions, Some Answers
Background. There are no prospective data regarding the management of pulmonary cryptococcosis in the immunocompetent patient. Clinical guidelines recommend oral fluconazole for patients with mild to moderate symptoms and amphotericin B plus flucytosine followed by fluconazole for severe disease. It is unclear whether patients who have histological evidence of Cryptococcus neoformans but negat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Opinion on Drug Safety
سال: 2016
ISSN: 1474-0338,1744-764X
DOI: 10.1080/14740338.2017.1248401